69584-46-9Relevant articles and documents
5-MEMBERED HETEROARYL CARBOXAMIDE COMPOUNDS FOR TREATMENT OF HBV
-
Page/Page column 49, (2020/05/28)
The present disclosure provides, in part, 5-membered heteroaryl carboxamide compounds, and pharmaceutical compositions thereof, useful for disruption of HBV core protein assembly, and methods of treating Hepatitis B (HBV) infection.
Antiinflammatory-antalgic cyclobutanecarboxylic acid derivatives. IV. Interest of cis-trans isomerism
Escale,Girard,Vergnon,et al.
, p. 449 - 452 (2007/10/13)
-